Miscellaneous Malignancies | Norton Healthcare

Indication: Miscellaneous Malignancies

An open-label, multi-center, phase 1b/2 study to evaluate the safety and efficacy of copanlisib in combination with nivolumab in patients with advanced solid tumors

Advanced Solid Tumors

Drug Study

Principal Investigator: Jaspreet Grewal, M.D.
Norton Cancer Institute

Sponsor: Bayer Healthcare Pharmaceuticals

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.